)
Tinnitus and Hearing Loss Are Far More Common in Musicians Than Non-Musicians
A new meta-analysis found musicians have much higher rates of tinnitus, hearing loss, and hyperacusis than non-musicians, with risk seen across musical genres.
Hearing Aid News
News about hearing aids, hearing loss, cochlear implants, and more
Page 6 of 34
)
Brain-Imaging Study Suggests Age-Related Hearing Loss is Associated with Cognitive Decline
eNeuro study links age-related hearing loss (presbycusis) to cognitive test scores using an MRI Functional–Structural Ratio.
)
)
Tinnitus and Employment: Study Finds Productivity Strain, Reduced Hours, and Job Loss
New research finds tinnitus can harm workplace productivity and job retention. Survey data link symptoms to reduced hours or leaving work; online CBT showed benefits.
){kind=logo}
Envoy Medical Sets Terms for Upsized Public Offering, Targeting Up to $78 Million
Envoy Medical prices an upsized public offering: $30M upfront and up to $78M in total gross proceeds, with milestone warrants tied to the Acclaim cochlear implant.
){kind=logo}
Demant Reports 2025 Revenue Growth but Lower Profits, Forcing Cost Cutting Program
Demant’s 2025 Financial results show 5% revenue growth but about 7% lower profits, prompting a cost-saving plan with 700 job cuts; Oticon says U.S. provider support won’t be impacted.
)
Ear Professionals Group Acquires Soundly
Ear Professionals Group (UnitedHealthcare Hearing, EPIC, AARP Hearing Solutions) acquires Soundly to bridge online hearing education with in-clinic care; integration begins March 2026.
)
ELEHEAR Delight Debuts at CES 2026: AI-Powered In-Ear OTC Hearing Aid
Elehear leverages its successful Beyond Pro platform to create an impressively compact OTC hearing aid that focuses on speech clarity, comfort, Bluetooth streaming, and a wider user base.
)
ReSound Unveils Custom Savi CIC and Auracast-enabled ITC; NAL-NL3 Software Upgrade
GN debuts new ReSound Savi ITC and CIC custom hearing aids with Auracast plus Smart Fit 2.3 and future NAL-NL3 support.
)
Eli Lilly Taps Seamless Therapeutics in $1.12 BB Hearing Loss Gene-Editing Collaboration
Germany-based Seamless Therapeutics inks a Lilly hearing-loss gene-editing collaboration worth up to $1.12B+ in milestones, plus upfront and R&D funding.
)
Oticon Zeal Launch: NXT Design to “Change the Game” for Invisible, Rechargeable Hearing Aids
Oticon Zeal combines CIC-like invisibility with rechargeability, AI/DNN processing, and Bluetooth LE Audio streaming. Includes Fast Pair, Auracast, and instant-fit workflow.
)
CES 2026: Three Takeaways for Hearing Healthcare
CES 2026 highlights: China’s OTC hearing aids become truly impressive, hearing/captioning glasses surge, and Auracast is in the wings for accessibility mainstream.
)
Study: Hearing Aid Rx Not Linked to Better Cognition, But Lower Dementia Risk
Study of 2,777 older adults: hearing-aid prescriptions didn’t improve cognitive test scores but were linked to a 33% lower dementia risk.